论文信息 - Updated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer. - 字舞流文

Updated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer.

C. Redfern | K. Tamura | Shin-ichiro Takahashi | S. Modi | T. Yoshino | A. Takashima | J. Tsurutani | K. Yamaguchi | H. Kawakami | H. Taniguchi | M. Sugihara | H. Iwata | B. Li | K. Saito | Y. Fujisaki | T. Doi | J. Fisher